PEGylation of therapeutic proteins
By S. Jevševar, Menči Kunstelj, Vladka Gaberc Porekar. Biotechnology Journal, 2010
666 citations recorded by the source corpus.
Subfields: Molecular Biology, Radiology, Nuclear Medicine and Imaging
View Paper: https://www.semanticscholar.org/paper/4e6b4332b64316b0bc7fc7b1979ef58ce38e4427
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Molecular Biology
In Radiology, Nuclear Medicine and Imaging
Citations in the corpus
- Assessment of the Evolution of Cancer Treatment Therapies (2011, background): “Modified versions, such as PEGylation of fragments (modification of a molecule by linking of one or more polyethylene glycol chains) [44] to improve circulation half-life, glycosylation and Fc region engineering are some of the recent approaches used by researchers to overcome these problems [45].”
- PEGylation of Biopharmaceuticals: A Review of Chemistry and Nonclinical Safety Information of Approved Drugs. (2016, neutral): “Adagen®, pegadamase 96-126 5 [11-17] Patient d”
- An overview of active and passive targeting strategies to improve the nanocarriers efficiency to tumour sites (2019, background): “On the other hand, imidazole groups-([68,69]) or poly(b-amino ester)based([70]) polymers responsive to tumoral low pH as well as polymers having pH-sensitive chemical linkages, like acetal,([71]) hydrazine,([72,73]) vinyl and ortho esters,([74]) pHsensitive cell-penetrating peptides and cationic pol”